Parallax Volatility Advisers, L.P. Nektar Therapeutics Put Options Transaction History

Parallax Volatility Advisers, L.P.

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 16, 2022	BUY	$4.16 - $13.72 $446,784 - $1.47 Million	107,400 Added 537.0%	127,400 $687,000
Q3 2021 Nov 15, 2021	SELL	$13.07 - $18.84 $1.17 Million - $1.68 Million	-89,200 Reduced 81.68%	20,000 $359,000
Q4 2018 Feb 14, 2019	SELL	$30.43 - $56.65 $9.13 Million - $17 Million	-300,000 Reduced 73.31%	109,200 $3.59 Million
Q3 2018 Nov 14, 2018	BUY	$46.46 - $68.49 $232,300 - $342,450	5,000 Added 1.24%	409,200 $24.9 Million
Q2 2018 Aug 14, 2018	BUY	$46.25 - $104.45 $18.7 Million - $42.2 Million	404,200 New	404,200 $19.7 Million

145

139M

32.6K

14.1K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $174M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.